Evonik Aerosil: Product Range, Key Grades and Equivalent Alternatives

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Market Size 2026: Global Value, Growth Rate and Key Segments
  • Keywords: silica market trends
  • Published: 2026-11-20 12:18:30
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
An additional advantage of MSNs over other inorganic NPs is their relatively superior safety profile. A typical example is that the FDA has approved colloidal silica for use as a glidant in the production of tablets. 38 Also, the widely used food additive E511 consists of amorphous silica NPs with a diameter of 100 nm. 38 Importantly, there are numbers of clinical trials and clinical studies confirming the safety and efficacy of silica NPs when used in applications such as oral drug delivery, bioimaging and PTT. For instance, in a clinical study involving 12 volunteers, ordered MSNs were able to significantly increase the bioavailability of fenofibrate by 54%, far better than the commercially available product Lipanthyl. 39 In another clinical trial involving 16 patients with prostate cancer, gold-silica nanoshells (GSNs) enabled tumor ablation by photothermal action, eventually attaining effective tumor eradication in 94% (15/16) of patients. 40 The physiological toxicity of MSNs is closely related to particle size, morphology, and structural composition. Currently, lots of silica-based nanoformulations have been developed, and their systematic safety evaluation is a matter of ongoing concern. Nonetheless, there is no doubt that mesoporous silica-based NPs will always be more promising in the biomedical field than other inorganic NPs.

What Is 4N Silica? Purity Standards, Impurity Limits and Uses

Fused Silica vs Quartz: Differences in Structure, Purity and Applications
Patel, A. & Sant, S. Hypoxic tumor microenvironment: Chances to develop targeted therapies. Biotech. Adv. 34, 803-812 (2016). Article CAS Google Scholar
Silica as a Desiccant: Moisture Capacity, Types and Uses
Silica OEM: How Private-Label and Custom Silica Manufacturing Works
Silica for Skincare: Benefits for Oil Control, Texture and Soft-Focus Effects

Silica Free Flow Agent: Typical Dosage, Benefits and Best Grades

What is silica (SiO₂)?

bulk silica powder Kumar, P. et al. Highly luminescent biocompatible CsPbBr 3 @SiO 2 core-shell nanoprobes for bioimaging and drug delivery. J. Mater. Chem. B 8, 10337-10345 (2020). Article CAS PubMed Google Scholar

What is the difference between fumed silica and precipitated silica?

quartz sand supplier Egypt

What drives silica raw material prices?

hollow silica Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.

Cite this article: Silica Raw Materials News. "Silica Antiblocking Agent: How It Works, Particle Size Selection and Uses ." Published 2026-11-20 12:18:30. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.